216 related articles for article (PubMed ID: 267510)
1. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
Wang JJ; Freeman AI; Sinks LF
Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate as part of remission maintenance therapy for childhood acute lymphocytic leukemia: a Pediatric Oncology Group pilot study.
Frankel LS; Wang YM; Shuster J; Nitschke R; Doering EJ; Pullen J
J Clin Oncol; 1983 Dec; 1(12):804-9. PubMed ID: 6583318
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
[TBL] [Abstract][Full Text] [Related]
5. [New aspects of the determination of blood methotrexate levels in leukemic children].
Schuler D; Borsi J; Koós R; Révész T; Kardos G; Somló P
Monatsschr Kinderheilkd; 1986 Oct; 134(10):765-8. PubMed ID: 3467178
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.
Bleyer AW
Cancer Treat Rep; 1977 Nov; 61(8):1419-25. PubMed ID: 579164
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
9. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
Pitman SW; Frei E
Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
[TBL] [Abstract][Full Text] [Related]
10. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection.
Ramu A; Fusner JE
Isr J Med Sci; 1979 Jun; 15(6):494-9. PubMed ID: 582316
[TBL] [Abstract][Full Text] [Related]
12. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
14. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
[TBL] [Abstract][Full Text] [Related]
15. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Rosen G; Ghavimi F; Nirenberg A; Mosende C; Mehta BM
Cancer Treat Rep; 1977 Jul; 61(4):681-90. PubMed ID: 301781
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.
Evans WE; Abromowitch M; Crom WR; Relling MV; Bowman WP; Pui CH; Ochs J; Dodge R
NCI Monogr; 1987; (5):81-5. PubMed ID: 3481040
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma.
Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ
Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429
[TBL] [Abstract][Full Text] [Related]
19. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
